Company facts
- Industry
- Hospital & Medical Service Plans
- Headquarters
- Louisville, Kentucky
- Most recent report
- 8-K, filed Nov 9, 2026
- Incorporated
- Delaware
- Filings on record
- 1,007+ filings
- On EDGAR
- CIK 49071
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 35
News 8 of 152
- 8-K Other events Nov 9, 2026
- 8-K Quarterly results Nov 6, 2026
- 8-K Current report on a material event Oct 13, 2026
- 8-K Current report on a material event Oct 9, 2026
- 8-K Current report on a material event Sep 1, 2026
- 8-K Leadership change Jul 29, 2026
- 8-K Quarterly results Jul 29, 2026
- 8-K Current report on a material event Jun 1, 2026
Prospectuses and Registrations 8 of 40
- S-8 Registration statement for an employee plan Apr 16, 2026
- 424B5 Prospectus supplement for an offering Mar 6, 2026
- FWP Free writing prospectus Mar 5, 2026
- 424B5 Prospectus supplement for an offering Mar 5, 2026
- S-8 POS Post-effective amendment to an employee plan registration Dec 19, 2025
- 424B5 Prospectus supplement for an offering Mar 28, 2025
- FWP Free writing prospectus Mar 26, 2025
- 424B5 Prospectus supplement for an offering Mar 26, 2025
Proxies 8 of 24
- DEFR14A Mar 6, 2026
- DEFA14A Extra proxy material Mar 6, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 6, 2026
- DEFA14A Extra proxy material Mar 7, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 7, 2025
- PX14A6G Shareholder's own proxy material Mar 14, 2024
- DEFA14A Extra proxy material Mar 8, 2024
- DEF 14A Proxy statement for a shareholder vote Mar 8, 2024
Ownership 8 of 727
- 144 Notice of a proposed sale of restricted stock Nov 9, 2026
- 4 Insider reported a trade Oct 2, 2026
- 4 Insider reported a trade Sep 3, 2026
- 3 Insider reported their initial holding Aug 31, 2026
- 4 Insider reported a trade Aug 4, 2026
- 4 Insider reported a trade Aug 4, 2026
- 3 Insider reported their initial holding Jul 29, 2026
- 3 Insider reported their initial holding Jul 29, 2026
Other 8 of 29
- 11-K Employee stock plan report Jun 24, 2026
- 11-K Employee stock plan report Jun 24, 2026
- ARS Annual report sent to shareholders Mar 6, 2026
- POSASR Mar 5, 2026
- 11-K Employee stock plan report Jun 17, 2025
- 11-K Employee stock plan report Jun 17, 2025
- ARS Annual report sent to shareholders Mar 7, 2025
- 11-K Employee stock plan report Jun 20, 2024
What to read: Sep 2026 10-Q
SECSift found 3 of 17 sections worth reading, with 0 positive, 19 notable, and 2 negative flags.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Dense with company-specific facts: $908M MaxHealth buy, new BlackRock JV, RADV lawsuit win on appeal, $1B sub debt, segment results.Notable- Acquired MaxHealth for $908M cash in Feb 2026, adding ~$800M goodwill and $71M intangibles.
- Restructuring charges totaled $179M for nine months ended Sep 2026, down from $320M a year ago.
- CMS GLP-1 Bridge program started Jul 2026; net receipts from contract deposits were $2.0B in both Q3 and YTD.
- Pharmaceutical rebate receivables rose to $2.4B at Sep 2026 from $1.9B at Dec 2025.
- Securities lending collateral held was $818M at Sep 2026, up from $638M at Dec 2025.
- Interest-rate swaps decreased carrying value of senior notes by ~$556M at Sep 2026.
- New BlackRock JV replaced WCAS JV, removing $1.2B put liability; call options may require up to $1.1B-$1.2B in 2028-2030.
- Repurchased $103M of stock in nine months ended Sep 2026 at avg $182.13, vs $100M at $233.73 a year ago.
- Effective tax rate swung to 19.7% in Q3 2026 from (77.3)% in Q3 2025 due to prior-year business sale tax benefit.
- Issued $1B of 6.625% junior subordinated notes due 2056 in March 2026, netting ~$990M.
- Entered $1.5B in P-Cap arrangements providing on-demand capital; none drawn as of Sep 2026.
- Debt-to-capitalization ratio was 40.9% at Sep 2026, well under the 60% covenant.
- Medicare products were ~85% of total premiums and services revenue for nine months ended Sep 2026.
- Court vacated CMS RADV rule in Sep 2025; government appealed Nov 2025. Outcome uncertain.
- DOJ intervened in qui tam lawsuit in May 2025 alleging False Claims Act violations over call center broker payments.
Item 2
MD&A with detailed segment results, a major JV, an acquisition, and a new CMS program.Notable- New BlackRock JV valued at ~$2.8B replaced WCAS partnership; BlackRock majority-owned, call period extended to 2028, put removed.
- Favorable prior-period medical claims reserve development fell to $509M in the 2026 period from $913M in the 2025 period.
- Parent company cash dropped to $0.5B at Sep 30, 2026 from $1.5B at Dec 31, 2025, due to acquisitions and debt repayments.
Item 3
Quantified interest-rate risk with specific portfolio losses and sensitivity.
What changed: Sep 2026 vs. Jun 2026
About 4% of HUM's Sep 2026 10-Q is new information. 14 paragraphs were added, 149 changed, and 20 removed. Below are the most important lines SECSift identified.
Changed
- Net income fell to $162M (Q3 2026) from $694M (Q2 2026); diluted EPS to $1.33 from $5.73.
- Value creation charges rose to $25M (Q3 2026) from $56M (Q2 2026) for three months; $179M (9mo 2026) from $154M (6mo 2026).
- Impairment charges on minority investments fell to $3M (Q3 2026) from $21M (Q2 2026); $24M (9mo 2026) from $21M (6mo 2026).
- Minority-interest impairment charges changed to $3M and $24M for three and nine months ended Sep 30, 2026, from $21M for three and six months ended Jun 30, 2026.
- Net income for the three months ended Sep 30, 2026 was $162M, down from $195M in the same period of 2025.
- Other comprehensive loss for the three months ended Sep 30, 2026 was $519M, compared to income of $117M in 2025.
- Stock-based compensation for the three months ended Sep 30, 2026 was $67M, down from $83M in 2025.
- Exhibit 101 now covers the quarter ended September 30, 2026 (was June 30, 2026) and nine months (was six months).
- Individual MA members in value-based relationships rose to 4,123,700 (Sep 2026) from 4,118,700 (Jun 2026); 64% vs 64%.
- Table covers three months ended September 30, 2026, not June 30, 2026.
Everything here comes from Humana Inc's own filings on SEC EDGAR. The filing list is rechecked every hour. SECSift analysis was completed on Nov 6, 2026, from the 10-Q for Sep 2026.